✨ New Arrivals Just Dropped!Explore
Molecular Reagent Xpert® Xpress Sars-cov-2 Plus Clia Waived For Genexpert Xpress System (clia Waived) / Genexpert System With Touchscreen Running Cepheid Os (moderate Complexity) 10 Tests
- Xpert® Xpress CoV-2 plus, 510K, designed with 3 gene targets for a rapid, robust detection of SARS-CoV-2
- CLIA Waived Environment (GeneXpert Xpress), Moderate Complexity Environment (GeneXpert Dx or Infinity)
- The Xpert Xpress CoV-2 plus test is a real-time RT-PCR test intended for the qualitative detection of nucleic acid from the SARS-CoV-2 in nasopharyngeal swab or anterior nasal swab specimen obtained from individuals meeting COVID-19 clinical and/or epidemiological criteria, as well as individuals without symptoms or other reasons to suspect COVID-19 infection
- Results are for the identification of SARS-CoV-2 RNA
- Positive results are indicative of the presence of SARS-CoV-2 RNA; clinical correlation with patient history and other diagnostic information is necessary to determine patient infection status
- Positive results do not rule out bacterial infection or co-infection with other viruses
- Negative results do not preclude SARS-CoV-2 infection and should not be used as the sole basis for treatment or other patient management decisions
- Negative results must be combined with clinical observations, patient history, and epidemiological information
- The Xpert Xpress CoV-2 plus test is intended to be performed by trained users in both laboratory and near patient testing settings
- Fast and accurate results in as early as 20 minutes - with early assay termination for positives, otherwise, the full test runtime is 30 minutes
- Xpert® Xpress CoV-2 plus, 510K, designed with 3 gene targets for a rapid, robust detection of SARS-CoV-2
- CLIA Waived Environment (GeneXpert Xpress), Moderate Complexity Environment (GeneXpert Dx or Infinity)
- The Xpert Xpress CoV-2 plus test is a real-time RT-PCR test intended for the qualitative detection of nucleic acid from the SARS-CoV-2 in nasopharyngeal swab or anterior nasal swab specimen obtained from individuals meeting COVID-19 clinical and/or epidemiological criteria, as well as individuals without symptoms or other reasons to suspect COVID-19 infection
- Results are for the identification of SARS-CoV-2 RNA
- Positive results are indicative of the presence of SARS-CoV-2 RNA; clinical correlation with patient history and other diagnostic information is necessary to determine patient infection status
- Positive results do not rule out bacterial infection or co-infection with other viruses
- Negative results do not preclude SARS-CoV-2 infection and should not be used as the sole basis for treatment or other patient management decisions
- Negative results must be combined with clinical observations, patient history, and epidemiological information
- The Xpert Xpress CoV-2 plus test is intended to be performed by trained users in both laboratory and near patient testing settings
- Fast and accurate results in as early as 20 minutes - with early assay termination for positives, otherwise, the full test runtime is 30 minutes
$130.33
Original: $434.45
-70%Molecular Reagent Xpert® Xpress Sars-cov-2 Plus Clia Waived For Genexpert Xpress System (clia Waived) / Genexpert System With Touchscreen Running Cepheid Os (moderate Complexity) 10 Tests—
$434.45
$130.33Description
- Xpert® Xpress CoV-2 plus, 510K, designed with 3 gene targets for a rapid, robust detection of SARS-CoV-2
- CLIA Waived Environment (GeneXpert Xpress), Moderate Complexity Environment (GeneXpert Dx or Infinity)
- The Xpert Xpress CoV-2 plus test is a real-time RT-PCR test intended for the qualitative detection of nucleic acid from the SARS-CoV-2 in nasopharyngeal swab or anterior nasal swab specimen obtained from individuals meeting COVID-19 clinical and/or epidemiological criteria, as well as individuals without symptoms or other reasons to suspect COVID-19 infection
- Results are for the identification of SARS-CoV-2 RNA
- Positive results are indicative of the presence of SARS-CoV-2 RNA; clinical correlation with patient history and other diagnostic information is necessary to determine patient infection status
- Positive results do not rule out bacterial infection or co-infection with other viruses
- Negative results do not preclude SARS-CoV-2 infection and should not be used as the sole basis for treatment or other patient management decisions
- Negative results must be combined with clinical observations, patient history, and epidemiological information
- The Xpert Xpress CoV-2 plus test is intended to be performed by trained users in both laboratory and near patient testing settings
- Fast and accurate results in as early as 20 minutes - with early assay termination for positives, otherwise, the full test runtime is 30 minutes
